Mc Farland Pharmaceutical Product Lawyer, California


Caroline Farrell

Environmental Law
Status:  In Good Standing           Licensed:  25 Years

Susanna Gabriella Garza

General Practice
Status:  Suspended           Licensed:  23 Years

John Steve Dulcich

General Practice
Status:  In Good Standing           Licensed:  36 Years

Stephanie Arnold Leyendecker

General Practice
Status:  Retired           Licensed:  31 Years

Jimmy Wayne Harrott

General Practice
Status:  In Good Standing           Licensed:  35 Years

L Bryce Chase

General Practice
Status:  Inactive           Licensed:  49 Years

Roger Ernest Williams

General Practice
Status:  Suspended           Licensed:  50 Years

Marvin Dwain Smith

Commercial Real Estate
Status:  Inactive           Licensed:  62 Years

Free Help: Use This Form or Call 800-620-0900

Member Representative

Call me for fastest results!
800-620-0900

Free Help: Use This Form or Call 800-620-0900

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.


Free Help: Use This Form or Call 800-943-8690

Member Representative

Call me for fastest results!
800-943-8690

Free Help: Use This Form or Call 800-943-8690

By submitting this lawyer request, I confirm I have read and agree to the Consent to Receive Messages from all messaging and voice technologies including Email, Text, Phone, Terms of Use, and Privacy Policy. Information provided is not privileged or confidential.

TIPS

Easily find Mc Farland Pharmaceutical Product Lawyers and Mc Farland Pharmaceutical Product Law Firms. For more attorneys, search all Health Care areas including Medical Products & Devices, Medicare & Medicaid and Other Health Care attorneys.

SAMPLE LEGAL CASES

Conte v. Wyeth, Inc.

... of the drug, on two grounds: (1) Conte could not show that she or her physician relied upon warnings or product labeling disseminated by Wyeth; and (2) a name-brand pharmaceutical manufacturer owes no duty to individuals who take only generic versions of its product. ...

People v. Gann

... (Id. at p. 280.) Concluding that the two codefendants had misled investigators about their sales of large volumes of stock before the company announced that it had been denied approval for a key pharmaceutical product, the government indicted them for 1010 conspiracy to ...

In re Vioxx Class Cases

... Similarly, plaintiffs allege that Merck represented to prescribing physicians (through marketing representatives, product labels, direct-mailed letters, and published ... were as effective and/or safer." Plaintiffs also relied on the declaration of an expert in pharmaceutical economics to ...